GPT and hepatitis A virus infection: Both episodic hepatitis flares and intermittent ALT elevations may occur and repeat during anti-HBV therapy, which more frequently leads to the development of cirrhosis, hepatic decompensation, failure, or even death (Liaw et al., 1988; Chang and Liaw, 2014).